Neuland Laboratories Ltd Quarterly Result
Neuland Laboratories Ltd
NSE: NEULANDLAB
Net Profit - Last Quarter
Neuland Laboratories Ltd Quarterly Results Key Highlights
- The revenue of Neuland Laboratories Ltd for the Mar '26 is ₹ 788.71 crore as compare to the Dec '25 revenue of ₹ 447.76 crore.
- This represent the growth of 76.15% The ebitda of Neuland Laboratories Ltd for the Mar '26 is ₹ 319.79 crore as compare to the Dec '25 ebitda of ₹ 85.19 crore.
- This represent the growth of 275.38% The net profit of Neuland Laboratories Ltd for the Mar '26 is ₹ 212.67 crore as compare to the Dec '25 net profit of ₹ 40.57 crore.
- This represent the growth of 424.21%.
Neuland Laboratories Ltd Quarterly Results Analysis
Market Price of Neuland Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 18859.8 |
| 27 Jul 2026 | 18975.4 |
| 24 Jul 2026 | 18570.85 |
| 23 Jul 2026 | 18427.7 |
| 22 Jul 2026 | 18497.9 |
| 21 Jul 2026 | 18892.25 |
| 20 Jul 2026 | 18942.05 |
| 17 Jul 2026 | 18422.8 |
| 16 Jul 2026 | 18773.6 |
| 15 Jul 2026 | 19089.6 |
Historical Revenue of Neuland Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Neuland Laboratories Ltd
Historical EBITDA of Neuland Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Neuland Laboratories Ltd
Historical Net Profit of Neuland Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Neuland Laboratories Ltd
Neuland Laboratories Ltd News Hub
Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter
Net profit of Neuland Laboratories rose 58.16% to Rs 97.87 crore in the quarter ended June 2024 as a
Read more
01 Aug 24
Neuland Laboratories to declare Quarterly Result
Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2024
Read more
18 Oct 24
Neuland Laboratories consolidated net profit declines 63.20% in the September 2024 quarter
Net profit of Neuland Laboratories declined 63.20% to Rs 32.84 crore in the quarter ended September
Read more
06 Nov 24
Neuland Laboratories Ltd leads losers in 'A' group
Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and Triveni E
Read more
06 Nov 24
Document
Popular Search
About Neuland Laboratories Ltd
- Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
- The Company is engaged in manufacturing and selling of bulk drugs such as Salbutamol Sulphate, Terbutaline Sulphate, Labetalol Hydrochloride and Ciprofloxacin.
- Neuland Drugs & Pharmaceuticals Pvt.
- Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
- NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.
